Skip to content

Acrivon Therapeutics (ACRV) IPO deck

Acrivon Therapeutics is a precision oncology therapeutics company uniquely enabled by a differentiated proteomics-based patient selection platform.

This post is for subscribers only

Subscribe

Already have an account? Sign In

Latest